These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35722260)

  • 1. Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis.
    Puicón-Suárez JB; Zeña-Ñañez S; Failoc-Rojas VE
    PeerJ; 2022; 10():e13437. PubMed ID: 35722260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Disease 2019 and Chronic Kidney Disease - A Clinical Observational Study.
    Shankar M; Narasimhappa S; MuddeGowda MK; Siddappa MN; Ramprasad K; Lingaraj U
    Saudi J Kidney Dis Transpl; 2021; 32(3):744-753. PubMed ID: 35102917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
    Mithal A; Jevalikar G; Sharma R; Singh A; Farooqui KJ; Mahendru S; Krishnamurthy A; Dewan A; Budhiraja S
    Diabetes Metab Syndr; 2021; 15(1):169-175. PubMed ID: 33360081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.
    Rana R; Ranjan V; Kumar N; Chugh P; Khillan K; Gogia A; Rana DS; Ganguly NK
    Mol Cell Biochem; 2023 Jan; 478(1):149-160. PubMed ID: 35750979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID-19 in Mexico.
    Parra-Bracamonte GM; Parra-Bracamonte FE; Lopez-Villalobos N; Lara-Rivera AL
    Nephrology (Carlton); 2021 Mar; 26(3):248-251. PubMed ID: 33184959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study.
    Mata-Cases M; Franch-Nadal J; Real J; Cedenilla M; Mauricio D
    BMJ Open; 2019 Oct; 9(10):e031281. PubMed ID: 31662386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease.
    Román JL; García-Carro C; Agraz I; Toapanta N; Vergara A; Gabaldón A; Torres I; Bury R; Baldallo C; Serón D; Soler MJ
    Kidney Blood Press Res; 2021; 46(4):452-459. PubMed ID: 34098555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kidney disease in Colombia: Priority for risk management].
    Acuña L; Sánchez P; Soler LA; Alvis LF
    Rev Panam Salud Publica; 2016 Aug; 40(1):16-22. PubMed ID: 27706391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying undetected cases of chronic kidney disease in Mexico. Targeting high-risk populations.
    García-García G; Gutiérrez-Padilla AJ; Chávez-Iñiguez J; Pérez-Gómez HR; Mendoza-García M; González-De la Peña Mdel M; Tonelli M
    Arch Med Res; 2013 Nov; 44(8):623-7. PubMed ID: 24211755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study.
    Abdel-Qadir H; Austin PC; Sivaswamy A; Chu A; Wijeysundera HC; Lee DS
    BMC Public Health; 2023 Mar; 23(1):482. PubMed ID: 36915068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.
    Ozturk S; Turgutalp K; Arici M; Odabas AR; Altiparmak MR; Aydin Z; Cebeci E; Basturk T; Soypacaci Z; Sahin G; Elif Ozler T; Kara E; Dheir H; Eren N; Suleymanlar G; Islam M; Ogutmen MB; Sengul E; Ayar Y; Dolarslan ME; Bakirdogen S; Safak S; Gungor O; Sahin I; Mentese IB; Merhametsiz O; Oguz EG; Genek DG; Alpay N; Aktas N; Duranay M; Alagoz S; Colak H; Adibelli Z; Pembegul I; Hur E; Azak A; Taymez DG; Tatar E; Kazancioglu R; Oruc A; Yuksel E; Onan E; Turkmen K; Hasbal NB; Gurel A; Yelken B; Sahutoglu T; Gok M; Seyahi N; Sevinc M; Ozkurt S; Sipahi S; Bek SG; Bora F; Demirelli B; Oto OA; Altunoren O; Tuglular SZ; Demir ME; Ayli MD; Huddam B; Tanrisev M; Bozaci I; Gursu M; Bakar B; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Ates K
    Nephrol Dial Transplant; 2020 Dec; 35(12):2083-2095. PubMed ID: 33275763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic and clinical profile of black patients with chronic kidney disease attending a tertiary hospital in Johannesburg, South Africa.
    Meremo A; Paget G; Duarte R; Dickens C; Dix-Peek T; Bintabara D; Naicker S
    PLoS One; 2022; 17(9):e0266155. PubMed ID: 36121812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Syndrome without Diabetes or Hypertension Still Necessitates Early Screening for Chronic Kidney Disease: Information from a Chinese National Cross-Sectional Study.
    Hong D; Zhang Y; Gao B; Wang J; Li G; Wang L; Zhang L;
    PLoS One; 2015; 10(7):e0132220. PubMed ID: 26161991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico).
    Salinas-Aguirre JE; Sánchez-García C; Rodríguez-Sanchez R; Rodríguez-Muñoz L; Díaz-Castaño A; Bernal-Gómez R
    Rev Clin Esp (Barc); 2022 May; 222(5):288-292. PubMed ID: 34620580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and risk factor prevalence in Saint Kitts and Nevis: a cross-sectional study.
    Crews DC; Campbell KN; Liu Y; Bussue O; Dawkins I; Young BA
    BMC Nephrol; 2017 Jan; 18(1):7. PubMed ID: 28056873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients.
    Koyyada R; Nagalla B; Tummala A; Singh AD; Patnam S; Barigala R; Kandala M; Krishna V; Manda SV
    Biomed Res Int; 2022; 2022():2349890. PubMed ID: 35402606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of chronic kidney disease in Brazilians with arterial hypertension and/or diabetes mellitus.
    Comini LO; de Oliveira LC; Borges LD; Dias HH; Batistelli CRS; Ferreira ES; da Silva LS; Moreira TR; da Costa GD; da Silva RG; Cotta RMM
    J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1666-1673. PubMed ID: 33460313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.